Literature DB >> 22071434

Usefulness of hemoglobin A1c as a criterion of dysglycemia in the definition of metabolic syndrome in Koreans.

Hong-Kyu Kim1, Chul-Hee Kim, Eun-Hee Kim, Sung-Jin Bae, Joong-Yeol Park.   

Abstract

To explore the utility of the HbA1c criterion in the definition of metabolic syndrome (MS) in Koreans, we cross-sectionally analyzed clinical and laboratory data on 11,293 non-diabetic Korean adults (aged 20-89 years, 34% women) collected during regular health checkups. Dysglycemia was defined as either fasting plasma glucose (FPG) ≥ 5.6 mmol/l or HbA1c ≥ 5.7%. The prevalence of MS as judged by the HbA1c criterion alone (17.8%) was significantly less than that determined by FPG level alone (24.5%). Use of a combination of both criteria slightly increased the prevalence of MS (26.0%). Among the 2953 subjects categorized as having MS using the combined criteria, 929 (31%) were diagnosed by the FPG criterion alone, 177 (6%) by the HbA1c criterion alone, and 1847 (63%) using both criteria. The group diagnosed using FPG values alone had significantly higher BMI, waist circumference, blood pressure, fasting plasma insulin levels, and insulin resistance index compared with those in the group diagnosed using HbA1c levels alone. In men, the brachial-ankle pulse wave velocity was significantly higher and the HDL-cholesterol level was lower in the HbA1c-alone group. Therefore, employment of the HbA1c criterion may be useful to define MS in subjects at increased risk for atherosclerosis.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22071434     DOI: 10.1016/j.diabres.2011.10.012

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome.

Authors:  Parco M Siu; Queenie S Yuen
Journal:  Diabetol Metab Syndr       Date:  2014-11-06       Impact factor: 3.320

2.  Impact of hemoglobin A1c-based criterion on diagnosis of prediabetes: The Korea National Health and Nutrition Examination Survey 2011.

Authors:  Chul-Hee Kim; Hong-Kyu Kim; Bo-Yeon Kim; Chan-Hee Jung; Ji-Oh Mok; Sung-Koo Kang
Journal:  J Diabetes Investig       Date:  2014-06-18       Impact factor: 4.232

3.  Comparative Abilities of Fasting Plasma Glucose and Haemoglobin A1c in Predicting Metabolic Syndrome among Apparently Healthy Normoglycemic Ghanaian Adults.

Authors:  Nafiu Amidu; William Kwame Boakye Ansah Owiredu; Lawrence Quaye; Peter Paul Mwinsanga Dapare; Yussif Adams
Journal:  Int J Chronic Dis       Date:  2019-07-24

4.  Discordance between Fasting Plasma Glucose (FPG) and HbA1c in Diagnosing Diabetes and Pre-diabetes in The Malaysian Cohort.

Authors:  Nor Azian Abdul Murad; Noraidatulakma Abdullah; Mohd Arman Kamaruddin; Nazihah Abd Jalal; Norliza Ismail; Nurul Ain Mhd Yusof; Norlaila Mustafa; Rahman Jamal
Journal:  J ASEAN Fed Endocr Soc       Date:  2021-07-19

5.  Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline.

Authors:  Gabriela Saravia; Fernando Civeira; Yamilee Hurtado-Roca; Eva Andres; Montserrat Leon; Miguel Pocovi; Jose Ordovas; Eliseo Guallar; Antonio Fernandez-Ortiz; Jose Antonio Casasnovas; Martin Laclaustra
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

6.  Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study.

Authors:  Carolina Giráldez-García; F Javier Sangrós; Alicia Díaz-Redondo; Josep Franch-Nadal; Rosario Serrano; Javier Díez; Pilar Buil-Cosiales; F Javier García-Soidán; Sara Artola; Patxi Ezkurra; Lourdes Carrillo; J Manuel Millaruelo; Mateu Seguí; Juan Martínez-Candela; Pedro Muñoz; Albert Goday; Enrique Regidor
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.